Category Archives: Pharma

Business Executives in Pharma Biotech Industry

Posted on December 11, 2011 by MyOrbit-Team| Leave a comment

Patrick Mahaffy, CEO & Founder, Clovis Oncology
Dan Burgess, CEO & Founder, Rempex Pharmaceuticals
Faheem Hasnain, President & CEO, Receptos
Remi Brouard, Vice President External Innovation, Sanofi-Aventis R&D
Polly Murphy, Vice President, Worldwide Business Development, Pfizer
Mark Noguchi, Gloabl Head of Alliance Management, Roche
Roger Pomerantz, SVP and Head Worldwide Licensing, Merck
Mark Edwards, Managing Director, Bioscience Advisors
George Golumbeski, Senior Vice President Business Development, Celgene Corporation
Kurt Graves, Executive Chairman, Intarcia Therapeutics, Inc.
Natasha Hernday, VP of Corporate Development, Seattle Genetics Continue reading →

→ Leave a comment

Posted in Biotech, Business Development, People, Pharma

Swine Flu vaccine update: WHO raises alert level to 5

Posted on April 30, 2009 by MyOrbit-Team| 3 Comments

New swine flu cases continue to emerge, and its not clear who exactly is the patient zero in this case, and when it really started. For now, we will continue to go with the proposed name of a Mexican boy.

This is a new strain of the flu virus and currently there is no tested/proven Swine Flu vaccine, though Tamiflu, which was tested for Bird Flu, could be used to strengthen the immunity. Learn more here: Swine Flu Vaccine- Tamiflu

U.S. scientists hope to have a key ingredient for a swine flu vaccine ready in early May, though commercial production can only happen by September.

→ 3 Comments

Posted in Geo-Americas, Geo-APAC, Geo-Europe, Healthcare & Medicine, MyOrbit Blogs, Pharma

Improving biotech status of Hong Kong

Posted on October 3, 2007 by MyOrbit-Team| Leave a comment

The Hong Kong Jockey Club Institute of Chinese Medicine recently signed a memorandum of understanding (MOU) with Canada’s national food and biotech research institute AFMNet, one of four between Hong Kong and Canadian organisations.



AFMNet Chairman Dr Murray McLaughlin says the MOUs help to develop the research and expertise available on the medicinal benefits of plants, by using Chinese herbal techniques. Co-operation will hasten Hong Kong’s goal to become a regional biotech center. There are also benefits for Hong Kong institutes in using the Canadian synchrotron, the light beam technology that facilitates analysis and diagnostic work across wide industrial and agricultural fields. It could make sense for Hong Kong to develop its own synchrotron, Dr McLaughlin adds.




About this Video: This video has been produced by HKTDC Hong Kong Trade Development Council (www.tdctrade.com), which is the global marketing arm and service hub for Hong Kong-based manufacturers, traders and service exporters, with more than 40 offices worldwide. Thanks to Irene Wong, the Webcast Producer of HKTDC for sharing the video. She can be reached at: tdctrade [at] tdc.org.hk ; MyOrbit will continue to show business update videos of Hong Kong and Asia-Pacific region.

→ Leave a comment

Posted in Biotech, Business Development, Business Strategy, Contracts & Legal, Geo-APAC, Healthcare & Medicine, Innovation, Intellectual Property, MyOrbit Blogs, Pharma

Do you know your fat facts?

Posted on October 2, 2007 by MyOrbit-Team| Leave a comment

Willing to be challenged on your understanding of fats and oils in the diet? Dr. Steven Whiting, founder of The Institute of Nutritional Science, poses some direct questions to our assumed ways of using oils and fats based on his research, which seems to show different results. The text and video on the following link is definitely worth checking out: http://healthcare-journal.com/understanding-fats-and-oils-in-the-diet/

→ Leave a comment

Posted in Healthcare & Medicine, Lifestyle, New Media, Pharma